Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages

Fig. 4

CTA & SALL4-specific T cell response magnitude was analyzed according to 1-year prognosis after TACE + RFA. There were 41 HCC patients (early-stage vs. advanced-stage: 25 vs. 16) that achieved complete ablation effect, and 24 patients developed recurrence while 17 patients among them didn’t get recurrence at 1 year after treatment. Each dot represents one tumour-specific T cell response. Values were compared by Mann-Whitney U-test

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us